Long-Term Neurocognitive Outcome in Patients With Continuous Flow Left Ventricular Assist Device

Sung Min Cho, Darlene Floden, Kristie Wallace, Nicholas Hiivala, Susan Joseph, Jeffrey Teuteberg, Joseph G. Rogers, Francis D. Pagani, Nahush Mokadam, David Tirschwell, Song Li, Randall C. Starling, Claudius Mahr, Ken Uchino

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: The authors sought to examine the long-term cognitive outcome of patients with continuous flow left ventricular assist device (CF-LVAD). Background: Data on long-term neurocognitive outcome in LVAD are limited. We examined the neurocognitive outcome of patients who received a CF-LVAD as destination therapy. Methods: Patients with HeartWare (HVAD) and HeartMate II who were enrolled in the ENDURANCE and ENDURANCE Supplemental trials were eligible. Cognition was evaluated with neuropsychological testing preoperatively and at 6, 12, and 24 months after implantation. General linear models identified demographic, disease, and treatment factors that predicted decline on each neurocognitive measure. Results: Of 668 patients who completed baseline testing and at least 1 follow-up evaluation, 552 were impaired at baseline on at least 1 cognitive measure. At each follow-up, approximately 23% of tested patients declined and 20% improved relative to baseline on at least 1 cognitive measure. Of those who were intact at baseline, only 10%-12% declined in delayed memory and 11%-16% declined in executive function at all 3 follow-ups. For patients impaired at baseline, delayed memory decline was associated with the HVAD device and male sex, whereas executive function decline was associated with the HVAD device and stroke during CF-LVAD support. For patients intact at baseline, male sex and history of hypertension were associated with decline in immediate memory and executive function, respectively. Conclusions: Neurocognitive function remained stable or improved for most patients (∼80%) with CF-LVAD at 6, 12, and 24 months after implantation. Male sex, hypertension, HVAD, and stroke were associated with cognitive decline.

Original languageEnglish (US)
Pages (from-to)839-851
Number of pages13
JournalJACC: Heart Failure
Volume9
Issue number11
DOIs
StatePublished - Nov 2021

Keywords

  • cognition
  • continuous flow left ventricular assist device
  • left ventricular assist device
  • neurocognitive outcome
  • neurologic complication

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Long-Term Neurocognitive Outcome in Patients With Continuous Flow Left Ventricular Assist Device'. Together they form a unique fingerprint.

Cite this